News
APUS
2.105
-3.00%
-0.065
Apimeds Restructures Board and Appoints New Director
TipRanks · 7h ago
Apimeds Pharmaceuticals Enters First Amendment To Settlement Agreement On Sept. 10; Board To Consist Solely Of Four Members During Interim Period; Board To Expand To Seven Members After Interim Period; Amends Settlement Agreement With Inscobee Parties
Benzinga · 8h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 1d ago
Weekly Report: what happened at APUS last week (0831-0904)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/02 17:06
Weekly Report: what happened at APUS last week (0824-0828)?
Weekly Report · 08/31 09:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 08/27 17:06
Weekly Report: what happened at APUS last week (0817-0821)?
Weekly Report · 08/24 09:40
Apimeds Secures Key Apitox Rights via FreeT Agreement
TipRanks · 08/21 21:27
Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On Aug 19, 2026; Freet Assigns All Apitox-Related Rights To Apimeds Pharmaceuticals; Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation For Apitox
Benzinga · 08/21 21:17
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 08/21 12:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 08/18 21:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 08/18 12:06
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 08/17 21:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/17 12:06
Weekly Report: what happened at APUS last week (0810-0814)?
Weekly Report · 08/17 09:40
Weekly Report: what happened at APUS last week (0803-0807)?
Weekly Report · 08/10 09:38
*Apimeds Pharmaceuticals US Names Christopher Kim Chief Scientific Officer
Dow Jones · 08/06 22:28
Apimeds Appoints Chief Scientific Officer to Advance APITOX
TipRanks · 08/06 22:16
Weekly Report: what happened at APUS last week (0727-0731)?
Weekly Report · 08/03 09:38
More
Webull provides a variety of real-time APUS stock news. You can receive the latest news about APIMEDS PHARMACEUTICALS US INC through multiple platforms. This information may help you make smarter investment decisions.
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.